ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preclinical Imaging (In-VIVO) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7A6302
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Preclinical Imaging In VIVO Market Insights and Forecast to 2028
BUY CHAPTERS

Global Preclinical Imaging (In-VIVO) Market Research Report 2025

Code: QYRE-Auto-7A6302
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PerkinElmer Inc
Bruker Corporation
FujiFilm Holdings
Mediso
Milabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec

Preclinical Imaging (In-VIVO) Market Size

The global market for Preclinical Imaging (In-VIVO) was valued at US$ 749 million in the year 2024 and is projected to reach a revised size of US$ 949 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Preclinical Imaging (In-VIVO) Market

Preclinical Imaging (In-VIVO) Market

North American market for Preclinical Imaging (In-VIVO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Preclinical Imaging (In-VIVO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Preclinical Imaging (In-VIVO) in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Preclinical Imaging (In-VIVO) include PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences, Trifoil Imaging, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical Imaging (In-VIVO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Imaging (In-VIVO).
The Preclinical Imaging (In-VIVO) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preclinical Imaging (In-VIVO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Imaging (In-VIVO) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Preclinical Imaging (In-VIVO) Market Report

Report Metric Details
Report Name Preclinical Imaging (In-VIVO) Market
Accounted market size in year US$ 749 million
Forecasted market size in 2031 US$ 949 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Equipment
  • Reagent
Segment by Application
  • Oncology
  • Cardio and Vascular
  • Neurology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences, Trifoil Imaging, Miltenyi Biotec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Preclinical Imaging (In-VIVO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Preclinical Imaging (In-VIVO) Market growing?

Ans: The Preclinical Imaging (In-VIVO) Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Preclinical Imaging (In-VIVO) Market size in 2031?

Ans: The Preclinical Imaging (In-VIVO) Market size in 2031 will be US$ 949 million.

Who are the main players in the Preclinical Imaging (In-VIVO) Market report?

Ans: The main players in the Preclinical Imaging (In-VIVO) Market are PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences, Trifoil Imaging, Miltenyi Biotec

What are the Application segmentation covered in the Preclinical Imaging (In-VIVO) Market report?

Ans: The Applications covered in the Preclinical Imaging (In-VIVO) Market report are Oncology, Cardio and Vascular, Neurology, Others

What are the Type segmentation covered in the Preclinical Imaging (In-VIVO) Market report?

Ans: The Types covered in the Preclinical Imaging (In-VIVO) Market report are Equipment, Reagent

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Equipment
1.2.3 Reagent
1.3 Market by Application
1.3.1 Global Preclinical Imaging (In-VIVO) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardio and Vascular
1.3.4 Neurology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical Imaging (In-VIVO) Market Perspective (2020-2031)
2.2 Global Preclinical Imaging (In-VIVO) Growth Trends by Region
2.2.1 Global Preclinical Imaging (In-VIVO) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Preclinical Imaging (In-VIVO) Historic Market Size by Region (2020-2025)
2.2.3 Preclinical Imaging (In-VIVO) Forecasted Market Size by Region (2026-2031)
2.3 Preclinical Imaging (In-VIVO) Market Dynamics
2.3.1 Preclinical Imaging (In-VIVO) Industry Trends
2.3.2 Preclinical Imaging (In-VIVO) Market Drivers
2.3.3 Preclinical Imaging (In-VIVO) Market Challenges
2.3.4 Preclinical Imaging (In-VIVO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical Imaging (In-VIVO) Players by Revenue
3.1.1 Global Top Preclinical Imaging (In-VIVO) Players by Revenue (2020-2025)
3.1.2 Global Preclinical Imaging (In-VIVO) Revenue Market Share by Players (2020-2025)
3.2 Global Preclinical Imaging (In-VIVO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Preclinical Imaging (In-VIVO) Revenue
3.4 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio
3.4.1 Global Preclinical Imaging (In-VIVO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Imaging (In-VIVO) Revenue in 2024
3.5 Global Key Players of Preclinical Imaging (In-VIVO) Head office and Area Served
3.6 Global Key Players of Preclinical Imaging (In-VIVO), Product and Application
3.7 Global Key Players of Preclinical Imaging (In-VIVO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical Imaging (In-VIVO) Breakdown Data by Type
4.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Type (2020-2025)
4.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2026-2031)
5 Preclinical Imaging (In-VIVO) Breakdown Data by Application
5.1 Global Preclinical Imaging (In-VIVO) Historic Market Size by Application (2020-2025)
5.2 Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Preclinical Imaging (In-VIVO) Market Size (2020-2031)
6.2 North America Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025)
6.4 North America Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical Imaging (In-VIVO) Market Size (2020-2031)
7.2 Europe Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025)
7.4 Europe Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size (2020-2031)
8.2 Asia-Pacific Preclinical Imaging (In-VIVO) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2020-2025)
8.4 Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical Imaging (In-VIVO) Market Size (2020-2031)
9.2 Latin America Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025)
9.4 Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size (2020-2031)
10.2 Middle East & Africa Preclinical Imaging (In-VIVO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025)
10.4 Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer
11.1.1 PerkinElmer Company Details
11.1.2 PerkinElmer Business Overview
11.1.3 PerkinElmer Preclinical Imaging (In-VIVO) Introduction
11.1.4 PerkinElmer Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.1.5 PerkinElmer Recent Development
11.2 Bruker Corporation
11.2.1 Bruker Corporation Company Details
11.2.2 Bruker Corporation Business Overview
11.2.3 Bruker Corporation Preclinical Imaging (In-VIVO) Introduction
11.2.4 Bruker Corporation Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.2.5 Bruker Corporation Recent Development
11.3 FUJIFILM Holdings
11.3.1 FUJIFILM Holdings Company Details
11.3.2 FUJIFILM Holdings Business Overview
11.3.3 FUJIFILM Holdings Preclinical Imaging (In-VIVO) Introduction
11.3.4 FUJIFILM Holdings Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.3.5 FUJIFILM Holdings Recent Development
11.4 Mediso
11.4.1 Mediso Company Details
11.4.2 Mediso Business Overview
11.4.3 Mediso Preclinical Imaging (In-VIVO) Introduction
11.4.4 Mediso Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.4.5 Mediso Recent Development
11.5 MILabs B.V.
11.5.1 MILabs B.V. Company Details
11.5.2 MILabs B.V. Business Overview
11.5.3 MILabs B.V. Preclinical Imaging (In-VIVO) Introduction
11.5.4 MILabs B.V. Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.5.5 MILabs B.V. Recent Development
11.6 MR Solutions
11.6.1 MR Solutions Company Details
11.6.2 MR Solutions Business Overview
11.6.3 MR Solutions Preclinical Imaging (In-VIVO) Introduction
11.6.4 MR Solutions Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.6.5 MR Solutions Recent Development
11.7 Aspect Imaging
11.7.1 Aspect Imaging Company Details
11.7.2 Aspect Imaging Business Overview
11.7.3 Aspect Imaging Preclinical Imaging (In-VIVO) Introduction
11.7.4 Aspect Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.7.5 Aspect Imaging Recent Development
11.8 LI-COR Biosciences
11.8.1 LI-COR Biosciences Company Details
11.8.2 LI-COR Biosciences Business Overview
11.8.3 LI-COR Biosciences Preclinical Imaging (In-VIVO) Introduction
11.8.4 LI-COR Biosciences Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.8.5 LI-COR Biosciences Recent Development
11.9 Trifoil Imaging
11.9.1 Trifoil Imaging Company Details
11.9.2 Trifoil Imaging Business Overview
11.9.3 Trifoil Imaging Preclinical Imaging (In-VIVO) Introduction
11.9.4 Trifoil Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.9.5 Trifoil Imaging Recent Development
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Company Details
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Preclinical Imaging (In-VIVO) Introduction
11.10.4 Miltenyi Biotec Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025)
11.10.5 Miltenyi Biotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
PerkinElmer Inc
Bruker Corporation
FujiFilm Holdings
Mediso
Milabs B.V.
MR Solutions
Aspect Imaging
LI-COR Biosciences
Trifoil Imaging
Miltenyi Biotec
List of Tables
 Table 1. Global Preclinical Imaging (In-VIVO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Equipment
 Table 3. Key Players of Reagent
 Table 4. Global Preclinical Imaging (In-VIVO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Preclinical Imaging (In-VIVO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Preclinical Imaging (In-VIVO) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Preclinical Imaging (In-VIVO) Market Share by Region (2020-2025)
 Table 8. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Preclinical Imaging (In-VIVO) Market Share by Region (2026-2031)
 Table 10. Preclinical Imaging (In-VIVO) Market Trends
 Table 11. Preclinical Imaging (In-VIVO) Market Drivers
 Table 12. Preclinical Imaging (In-VIVO) Market Challenges
 Table 13. Preclinical Imaging (In-VIVO) Market Restraints
 Table 14. Global Preclinical Imaging (In-VIVO) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Preclinical Imaging (In-VIVO) Market Share by Players (2020-2025)
 Table 16. Global Top Preclinical Imaging (In-VIVO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2024)
 Table 17. Ranking of Global Top Preclinical Imaging (In-VIVO) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Preclinical Imaging (In-VIVO) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Preclinical Imaging (In-VIVO), Headquarters and Area Served
 Table 20. Global Key Players of Preclinical Imaging (In-VIVO), Product and Application
 Table 21. Global Key Players of Preclinical Imaging (In-VIVO), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Preclinical Imaging (In-VIVO) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2020-2025)
 Table 25. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Type (2026-2031)
 Table 27. Global Preclinical Imaging (In-VIVO) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2020-2025)
 Table 29. Global Preclinical Imaging (In-VIVO) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Preclinical Imaging (In-VIVO) Revenue Market Share by Application (2026-2031)
 Table 31. North America Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. PerkinElmer Company Details
 Table 47. PerkinElmer Business Overview
 Table 48. PerkinElmer Preclinical Imaging (In-VIVO) Product
 Table 49. PerkinElmer Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 50. PerkinElmer Recent Development
 Table 51. Bruker Corporation Company Details
 Table 52. Bruker Corporation Business Overview
 Table 53. Bruker Corporation Preclinical Imaging (In-VIVO) Product
 Table 54. Bruker Corporation Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 55. Bruker Corporation Recent Development
 Table 56. FUJIFILM Holdings Company Details
 Table 57. FUJIFILM Holdings Business Overview
 Table 58. FUJIFILM Holdings Preclinical Imaging (In-VIVO) Product
 Table 59. FUJIFILM Holdings Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 60. FUJIFILM Holdings Recent Development
 Table 61. Mediso Company Details
 Table 62. Mediso Business Overview
 Table 63. Mediso Preclinical Imaging (In-VIVO) Product
 Table 64. Mediso Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 65. Mediso Recent Development
 Table 66. MILabs B.V. Company Details
 Table 67. MILabs B.V. Business Overview
 Table 68. MILabs B.V. Preclinical Imaging (In-VIVO) Product
 Table 69. MILabs B.V. Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 70. MILabs B.V. Recent Development
 Table 71. MR Solutions Company Details
 Table 72. MR Solutions Business Overview
 Table 73. MR Solutions Preclinical Imaging (In-VIVO) Product
 Table 74. MR Solutions Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 75. MR Solutions Recent Development
 Table 76. Aspect Imaging Company Details
 Table 77. Aspect Imaging Business Overview
 Table 78. Aspect Imaging Preclinical Imaging (In-VIVO) Product
 Table 79. Aspect Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 80. Aspect Imaging Recent Development
 Table 81. LI-COR Biosciences Company Details
 Table 82. LI-COR Biosciences Business Overview
 Table 83. LI-COR Biosciences Preclinical Imaging (In-VIVO) Product
 Table 84. LI-COR Biosciences Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 85. LI-COR Biosciences Recent Development
 Table 86. Trifoil Imaging Company Details
 Table 87. Trifoil Imaging Business Overview
 Table 88. Trifoil Imaging Preclinical Imaging (In-VIVO) Product
 Table 89. Trifoil Imaging Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 90. Trifoil Imaging Recent Development
 Table 91. Miltenyi Biotec Company Details
 Table 92. Miltenyi Biotec Business Overview
 Table 93. Miltenyi Biotec Preclinical Imaging (In-VIVO) Product
 Table 94. Miltenyi Biotec Revenue in Preclinical Imaging (In-VIVO) Business (2020-2025) & (US$ Million)
 Table 95. Miltenyi Biotec Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Preclinical Imaging (In-VIVO) Picture
 Figure 2. Global Preclinical Imaging (In-VIVO) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Preclinical Imaging (In-VIVO) Market Share by Type: 2024 VS 2031
 Figure 4. Equipment Features
 Figure 5. Reagent Features
 Figure 6. Global Preclinical Imaging (In-VIVO) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Preclinical Imaging (In-VIVO) Market Share by Application: 2024 VS 2031
 Figure 8. Oncology Case Studies
 Figure 9. Cardio and Vascular Case Studies
 Figure 10. Neurology Case Studies
 Figure 11. Others Case Studies
 Figure 12. Preclinical Imaging (In-VIVO) Report Years Considered
 Figure 13. Global Preclinical Imaging (In-VIVO) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Preclinical Imaging (In-VIVO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Preclinical Imaging (In-VIVO) Market Share by Region: 2024 VS 2031
 Figure 16. Global Preclinical Imaging (In-VIVO) Market Share by Players in 2024
 Figure 17. Global Top Preclinical Imaging (In-VIVO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Imaging (In-VIVO) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Preclinical Imaging (In-VIVO) Revenue in 2024
 Figure 19. North America Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Preclinical Imaging (In-VIVO) Market Share by Country (2020-2031)
 Figure 21. United States Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Preclinical Imaging (In-VIVO) Market Share by Country (2020-2031)
 Figure 25. Germany Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Preclinical Imaging (In-VIVO) Market Share by Region (2020-2031)
 Figure 33. China Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Preclinical Imaging (In-VIVO) Market Share by Country (2020-2031)
 Figure 41. Mexico Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Preclinical Imaging (In-VIVO) Market Share by Country (2020-2031)
 Figure 45. Turkey Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Preclinical Imaging (In-VIVO) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. PerkinElmer Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 49. Bruker Corporation Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 50. FUJIFILM Holdings Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 51. Mediso Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 52. MILabs B.V. Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 53. MR Solutions Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 54. Aspect Imaging Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 55. LI-COR Biosciences Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 56. Trifoil Imaging Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 57. Miltenyi Biotec Revenue Growth Rate in Preclinical Imaging (In-VIVO) Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global In Vivo Preclinical Brain Imaging Devices Market Research Report 2024
Small Animal Imaging In Vivo Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In vivo Imaging Camera Market Research Report 2024
Global In Vivo Imaging Reagents Market Research Report 2025
Global Preclinical Small Animal Imaging System Market Insights Forecast to 2030
Global Preclinical In vivo Imaging Market Research Report 2024
Global Preclinical MRI Equipment Market Research Report 2024
Clinical Trial Imaging System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vivo Preclinical Imaging System Market Research Report 2024
Global Full Spectrum Fluorescence In Vivo Imaging System Market Research Report 2024
Global Preclinical In vivo Imaging System Market Insights Forecast to 2030
Global Preclinical Assets Market Research Report 2025
Global In Vivo Preclinical Imagers Market Research Report 2024
Global Preclinical Testing Service Market Research Report 2025
Global Optical Preclinical Imaging Market Insights Forecast to 2030
Global In Vivo Imaging System Microscopes Market Research Report 2025
Preclinical Positron Emission Tomography PET Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Animal In Vivo Optical 3D Imaging System Market Research Report 2024
Global In Vivo Imagers Market Research Report 2024
Global Pre Clinical Testing Service Market Research Report 2025

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions